The estimated Net Worth of Stephen Brad Cohen is at least $6.52 Million dollars as of 15 December 2021. Mr. Cohen owns over 47,345 units of Sensus Healthcare Inc stock worth over $4,883,840 and over the last 8 years he sold SRTS stock worth over $1,114,038. In addition, he makes $521,260 as Co-Founder and Executive Vice President - Strategic Initiatives and Dermatology Sales at Sensus Healthcare Inc.
Stephen has made over 19 trades of the Sensus Healthcare Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 47,345 units of SRTS stock worth $333,309 on 15 December 2021.
The largest trade he's ever made was selling 47,345 units of Sensus Healthcare Inc stock on 15 December 2021 worth over $333,309. On average, Stephen trades about 8,261 units every 97 days since 2016. As of 15 December 2021 he still owns at least 830,585 units of Sensus Healthcare Inc stock.
You can see the complete history of Mr. Cohen stock trades at the bottom of the page.
Stephen Brad Cohen serves as Co-Founder, Executive Vice President - Strategic Initiatives and Dermatology Sales of the Company. Mr. Cohen served as Regional Sales Manager for Xoft Inc., a medical device company that develops and commercializes miniaturized electronic brachytherapy (eBx) technology for radiation oncology applications, from 2008 to 2009. Prior to that, Mr. Cohen’s medical device sales and marketing experience includes having served as Regional Sales Manager for Diasonics, a developer and manufacturer of ultrasound and other medical imaging equipment, from 1985 to 1988, and from 1983 to 1985, as Regional Sales Manager for Technicare, a developer of CT, DR and MRI scanners and other medical imaging equipment that was acquired by Johnson and Johnson in 1986. Mr. Cohen has a bachelor’s degree from the University of Texas at Austin.
As the Co-Founder and Executive Vice President - Strategic Initiatives and Dermatology Sales of Sensus Healthcare Inc, the total compensation of Stephen Cohen at Sensus Healthcare Inc is $521,260. There are no executives at Sensus Healthcare Inc getting paid more.
Stephen Cohen is 60, he's been the Co-Founder and Executive Vice President - Strategic Initiatives and Dermatology Sales of Sensus Healthcare Inc since 2010. There are 8 older and 8 younger executives at Sensus Healthcare Inc. The oldest executive at Sensus Healthcare Inc is John Heinrich, 73, who is the Non-Executive Independent Director.
Stephen's mailing address filed with the SEC is 851 BROKEN SOUND PARKWAY NW STE 215, , BOCA RATON, FL, 33487.
Over the last 8 years, insiders at Sensus Healthcare Inc have traded over $8,288,024 worth of Sensus Healthcare Inc stock and bought 88,000 units worth $292,820 . The most active insiders traders include Joseph C Sardano, Stephen Brad Cohen, and Anthony Benedict Petrelli. On average, Sensus Healthcare Inc executives and independent directors trade stock every 29 days with the average trade being worth of $58,482. The most recent stock trade was executed by John Heinrich on 17 May 2024, trading 20,000 units of SRTS stock currently worth $123,400.
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
Sensus Healthcare Inc executives and other stock owners filed with the SEC include: